Overview

A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain

Status:
Completed
Trial end date:
2020-05-10
Target enrollment:
Participant gender:
Summary
This pilot study aims to evaluate the efficacy and safety of hemoporfin photodynamic therapy (PDT) with different light doses for port-wine stain (PWS) in 7-14 years old children. The population pharmacokinetics of hemoporfin in children will be investigated as well.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.